title: Molecular analysis of the relationship between specific vaginal bacteria and bacterial vaginosis metronidazole therapy failure.
abstract: Bacterial vaginosis frequently persists, even after treatment. The role of some strains of bacteria associated with bacterial vaginosis treatment failure remains poorly defined. The aim of our study was to define the risk of bacterial vaginosis treatment failure, including pre-treatment detection of specific vaginal bacteria. Bacterial vaginosis is present when the Nugent score is ≥7 and the modified Amsel criteria is positive. Women with bacterial vaginosis were treated with intravaginal metronidazole gel nightly for 5 nights. The 454 pyrosequencing method was used to detect bacteria in vaginal fluid. By univariate analysis, a history of bacterial vaginosis, intrauterine device use and the presence of Facklamia, Corynebacterium and Veillonella were significantly associated with bacterial vaginosis treatment failure. Lactobacillus crispatus, Lactobacillus pentosus and Megasphaera were significantly associated with curing bacterial vaginosis. After logistic regression analysis and detection of these bacteria for test-of-cure, we found that women who had a history of bacterial vaginosis had a higher incidence of bacterial vaginosis treatment failure, whereas women with L. crispatus had a lower incidence of treatment failure. Post-treatment sexual activity was not associated with the treatment effect. Our data suggested that treatment failure may be not caused by drug resistance. Rather, it has a closer relationship with the failed restoration of lactobacilli.
authors.affiliation: Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, 100034, China.
authors.forename: B
authors.initials: B
authors.lastname: Wang
authors.forename: B B
authors.initials: BB
authors.lastname: Xiao
authors.forename: C G
authors.initials: CG
authors.lastname: Shang
authors.forename: K
authors.initials: K
authors.lastname: Wang
authors.forename: R S
authors.initials: RS
authors.lastname: Na
authors.forename: X X
authors.initials: XX
authors.lastname: Nu
authors.forename: Q
authors.initials: Q
authors.lastname: Liao
mesh_terms: D000282:Administration, Intravaginal; D000293:Adolescent; D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification*; D058448:Biota; D005260:Female; D006801:Humans; D007778:Lactobacillus / Q000254:growth & development; D008795:Metronidazole / Q000627:therapeutic use*; D008875:Middle Aged; D017211:Treatment Failure; D014622:Vaginal Creams, Foams, and Jellies / Q000008:administration & dosage; D016585:Vaginosis, Bacterial / Q000188:drug therapy* / Q000382:microbiology*; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D014622:Vaginal Creams, Foams, and Jellies; D008795:Metronidazole